BioregulatorResearch
Vilon
Also known as: Lys-Glu · KE dipeptide
An ultra-short Khavinson dipeptide that reverses thymic involution, re-establishing youthful immune function in aging populations.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
Half-Life
~30 minutes
Typical Dose
10 mg daily (oral, cycled)
Administration
Oral capsule
Mechanism of Action
Epigenetic trigger that reactivates thymic epithelial cell gene expression, restoring T-cell differentiation capacity.
Key Research Areas
bioregulatorthymusimmunedipeptide
Frequently Asked Questions
What is Vilon?▾
An ultra-short Khavinson dipeptide that reverses thymic involution, re-establishing youthful immune function in aging populations.
How does Vilon work?▾
Epigenetic trigger that reactivates thymic epithelial cell gene expression, restoring T-cell differentiation capacity.
What is the recommended dosage for Vilon?▾
The typical research dosage is 10 mg daily (oral, cycled), administered via Oral capsule. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Vilon?▾
The half-life of Vilon is approximately ~30 minutes. This affects dosing frequency and timing in research protocols.
Is Vilon FDA approved?▾
Vilon is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.
Research Disclaimer
The information provided about Vilon is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.